Xenotransfusion (from Greek xenos- strange or foreign), a form of xenotransplantation, was initially defined as the transfer of blood from one species into the veins of another. In most cases, it is a transfer of blood between a non-human animal and a human. However, further experimentation has been done between various non-human animal species. This procedure can be performed without affecting the health of the donor, as only about 10% of their blood volume is used each time. Utilizing the unlimited blood supply from animal sources eliminates the risk of transmitting infectious diseases between humans.
In 1658, Dom Robert des Gabets, a French monk, introduced the idea of xenotransfusion at a scientific society meeting. This society later afforded the French Academy of Sciences. Currently there are not any laws prohibiting the practice of xenotransfusion, but some ethical issues have been identified by the Ethics Committee of the International Xenotransplantation Association (IXA). For example, the IXA sets standards and regulations for those planning to orchestrate clinical xenotransplantation trials. The IXA has identified three major ethical areas that require adequate attention: favorable risk and benefit assessment supported by pre-clinical data, lack of alternative treatment for participants, and minimizing the risk of infection by ensuring the highest biosafety regulations are followed for selected animal donors. These are just a few examples of the ethics behind xenotransplantation.
Jean-Baptiste Denis, a French physician, and Paul Emmerez, a surgeon, performed the first documented xenotransfusion on June 15, 1667. The transfusion occurred between a lamb and a 15-year old boy. Carotid artery blood from the lamb was introduced to a vein in the patient’s inner elbow, and the procedure ultimately resulted in a successful recovery. Denis and Emmerez performed multiple xenotransfusions together. On June 24, 1667, the duo performed a transfusion on a young Swedish nobleman. When they arrived, the patient had already lost his ability to speak and was practically unconscious. Shortly after the transfusion began, the patient was able to speak again. His health was improving until his condition grew progressively worse. A second transfusion took place, but it was unsuccessful, and the patient passed away.
Richard Lower, an English physician, performed a similar procedure on November 23, 1667. He successfully transfused the blood of a lamb to a 22-year old man. In both cases, the whole blood of the lamb was directly introduced into the vein of the patient. The direct introduction of blood was due to a lack of knowledge in preventative blood coagulation techniques at the time.
After several xenotransfusion procedures, some successful some not, the French Parliament prohibited the practice of these transfusions in 1670. The English Parliament, as well as the Pope, followed suit and prohibited the procedures shortly after.
Ethical arguments involving the pig for Xenotransfusion
Xenotransfusion uses non-human animals to aid in the shortage of blood for blood transfusion in humans. Although there needs to be more study on the topic some scientists are already considering the idea to use Sus scrofa domesticus for blood transfusion. To come up with this answer they tested many animals to see which one was the best candidate for blood donation. As a result, pig red blood cells (pRBCs) showed more characteristics similar to that of a human. Starting with RBC diameters (pig 4 to 8 μm: human 7.2 μm) and RBC counts (pig 5.7 to 6.9 million/ll; human 4.2 to 6.2 million/ll) and, RBC average lifespan (86 vs. 120 days). XTF has not been tested in humans, however current evidence shows that pRBCs will function normally in humans due to a relation between porcine blood groups and human ABO group system. In addition, it is possible to produce pigs with type O blood and it is also possible to genetically modify the pig to make its blood more compatible with humans. Sus scrofa domesticus’s blood will be used to save lives and to increase blood quantity. The organism will be kept alive and no serious harm will be involved in XTF. It will be similar to how blood is removed from humans. Only 10% of the animal’s blood volume will be used each time, therefore, it is ethically acceptable to raise pigs for periodical blood collection as it does not damage the health of the animal. It will also be ethical to use pRBCs on humans since it will not cause a severe harm on human’s health. At the moment XTF is not a real necessity because a lot of people are willing to donate their blood and there is not a significant shortage on blood. However, it represents a great opportunity for new science as well as an unlimited blood bank for blood transfusions.
- Roux, Françoise A.; Saï, Pierre; Deschamps, Jack-Yves (2007). "Xenotransfusions, past and present". Xenotransplantation 14 (3): 208–216. doi:10.1111/j.1399-3089.2007.00404.x. ISSN 0908-665X.
- Roux, Françoise A.; Saï, Pierre; Deschamps, Jack-Yves (2007). "Some ethical issues regarding xenotransfusion". Xenotransplantation 14 (3): 217–221. doi:10.1111/j.1399-3089.2007.00393.x. ISSN 0908-665X.
- Cozzi, Emanuele; Tallacchini, Mariachiara; Flanagan, Enda B.; Pierson III, Richard N.; Sykes, Megan; Vanderpool, Harold Y. (2009). "Chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework". Xenotransplantation 16 (4): 203–214. doi:10.1111/j.1399-3089.2009.00540.x. ISSN 0908-665X.
- Deschamps, Jack-Yves; Roux, Francoise A.; Sai, Pierre; Gouin, Edouard (2005). "History of xenotransplantation". Xenotransplantation 12 (2): 91–109. doi:10.1111/j.1399-3089.2004.00199.x. ISSN 0908-665X.
- Cooper, David (September 2003). "Porcine red blood cells as a source of blood transfusion in humans". xenotransplantation 10 (5): 384–386. doi:10.1034/j.1399-3089.2003.00092.x.
- Zhu, Alex (30 November 1999). "Introduction to porcine red blood cells: Implications for xenotransfusion". Seminars in Hematology 37 (2): 143–149. doi:10.1016/s0037-1963(00)90039-8.
- Françoise, Roux (May 2007). "Some Ethical Issues Regarding Xenotransfusion". Xenotransplantation 14 (3): 217–221. doi:10.1111/j.1399-3089.2007.00393.x.